Posters of 5th Congress of SEUD

ABNORMAL UTERINE BLEEDING
  1. A cesarean scar ectopic pregnancy Mansurah University experiency, Hossam Abdelfatah (Egypt)
  2. A core outcome set for heavy menstrual bleeding: what is this and why do we need it ? Natalie Cooper (United Kingdom)
  3. Complete molar pregnancy in a singleton pregnancy following intracytoplasmic sperm injection (ICSI). A case report, Ibrahim Ekbahloul (Egypt)
  4. Conservative management of synchronous intrauterine molar pregnancy and cervical ectopic pregnancy: a case report, Ibrahim Ekbahloul (Egypt)
  5. Histopathology and clinical outcomes of 151 women with postmenopausal bleeding treated with resectoscopic surgery, George Vilos (Canada)
  6. Hysteroscopic findings in patients with abnormal uterine bleeding in a Congolese population of Kinshasa, Republic Democratic of the Congo, Emmanuel Nzau-Ngoma (Congo)
  7. Outcomes after endometrial ablation in women with heavy menstrual bleeding. Retrospective case series, López Carrasco (Spain)
  8. Resectoscopic endometrial ablation does not adversely affect long-term clinical outcomes in women with atypical endometrial hyperplasia, Angelos Vilos (Canada)
  9. The HOPE study: evaluating the impact of an online educational resource for heavy menstrual bleeding on the patient–physician dynamic, Agnaldo Lopes Silva-Filho (Brazil)
  10. The menstrual bleeding questionnaire: assessing the performance of a short-form version of the patient-based assessment tool, Kristen Matteson (USA)
  11. Usage of uterine artery embolization in obstetrical practice, Bakhyt Abishev (Kazakhstan)
ENDOMETRIOSIS / ENDOMETRIUM
  1. Ablation and excision of endometriosis in a robotic-assisted CO2 laser surgery, Mona Orady (USA)
  2. Activated platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells, Qiuming Qi (China)
  3. Analysis of mutation in normal endometrium, deep infiltrating endometriosis and focal adenomyosis, Louis Marcellin (France)
  4. Application of bioluminescent technology in murine endometriosis model, Hermawan Wibisono (Japan)
  5. Apricot kernels stimulate apoptosis and modulation of redox balance in endometriosis, Ali Farid (Egypt)
  6. Association between vitamin D and endometriosis: a systematic review, Dimitrios Rafail Kalaitzopoulos (Switzerland)
  7. Benign multicystic peritoneal mesothelioma associated with endometriosis, massive hemorrhagic ascites, and uterine fibroid, Asuka Sato (Japan)
  8. Big right muscle endometriom, Nadim Abdelhak Soualili (Algeria)
  9. Bilateral endometrioma with severe hydroureteronephrosis and rising of creatinine level, Charintip Somprasit (Thailand)
  10. CA 125: predictive biomarker for severity of endometriosis, Lee Byong Ick (Republic of Korea)
  11. Can’t we avoid kidney loss in urinary tract endometriosis? Mension Eduard (Spain)
  12. Cesarean section scar endometriosis: a case report with images, Tina Ngan (Canada)
  13. Design of a non-interventional cohort study of women with pelvic pain associated with presumptive endometriosis, Stacey Missmer (USA)
  14. Endometriosis and menopause: current opinion, Dominoni Mattia (Italy)
  15. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute, Lu Yuan (China)
  16. Endometriosis in adolescents, Fantappiè Giulia (Italy)
  17. Endometriosis in all its states, Lyes Meguenni (Algeria)
  18. Evaluation of angiogenic biomarkers in plasma in ovarian and deep endometriosis. A pilot study, Taisiia Melnychuk (Spain)
  19. Examining endometriosis-associated pain in the Visanne Post-approval Observational Study, Bruno Imthurn (Switzerland)
  20. Fibrinolytic activity and total circulating microparticle levels in endometriosis, Crístian De Guirior (Spain)
  21. Generation of xenograft murine models of endometriosis, Taisiia Melnychuk (Spain)
  22. Hydronephrosis-ureteral squeezed by deep infiltrating endometriosis lesions, Zheng Yunxi (China)
  23. Incidental findings of urinary deep infiltrating endometriosis during hysterectomy for adenomyosis, Zheng Yunxi (China)
  24. Is there an interest to perform endometrial ablation concurrently with hysteroscopic polyp resection? Results from a prospective observational study, Antoine Bourret (France)
  25. Laparoscopic approach for coexisting vaginal endometriosis and uterine myoma, Sepideh Khodaverdi (Iran)
  26. Measurement of uterine volume in nullipara patients with endometriosis and its clinical significance, Chao Peng (China)
  27. Medical treatment for ureteral endometrisis: three cases and literature review, Xu Hong (China)
  28. Micro-RNA (145, 200a, 200b, 141) and serum Galectin-9 as a new non-invasive marker of endometriosis, Ali Farid M. Ali (Egypt)
  29. Mutation analysis of epithelial cells isolated from mouse model of deep infiltrative endometriosis, Mei Zi (China)
  30. Obstetrical and neonatal outcomes for fresh versus frozen-thrawed embryo transfer in women with endometriosis, Lauren Sebbag (France)
  31. Patterns of melatonin regulation in patients with genital endometriosis, Maria Yarmolinskaya (Russia)
  32. Peritoneal fluid leptin increased in peritoneal endometriosis infertility and its reversal by bromotemia, Ali Farid M. Ali (Egypt)
  33. Placenta, genetic and epigenetic a new hypothesis for endometriosis, Ali Farid M. Ali (Egypt)
  34. Laparoscopic Treatment of ovarian endometrioma with CO2 laser flexible-fiber, Di Donato Violante (Italy)
  35. Primary umbilical endometriosis: case report, Aline Brum (Brazil)
  36. Profiles of patients with endometriosis design for predictive improvement of pain and quality of life after surgery, Nicolas Bourdel (France)
  37. Recurrence of severe endometriosis of ovary with poor ovarian reserve in young aged women: case report, Nipattha Vinayanuvattikhun (Thailand)
  38. Risk factors of postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 cases, Xiaoyan Li Xiaoyan (China)
  39. Robotic surgery for deep endometriosis. Current evidence, Alexander Popov (Russia)
  40. Robotic surgery in incipient and advanced stages of endometriosis, Francesca Frîncu (Romania)
  41. Study of postoperative pain in patients with pelvic endometriosis, Francesca Frîncu (Romania)
  42. Supporting adolescents with endometriosis within the school setting: a Canadian perspective, Jalisa Gittens (Canada)
  43. The characteristics of novel endometriosis models in cynomolgus monkeys, that including not only endometrial stromal and glands, but also myofibrosis, Ayako Nishimoto-Kakiuchi (Japan)
  44. The different incidence of developed side in ovarian endometrioma, Yong Il Ji (Republic of Korea)
  45. The face of endometriosis: the use of social media to talk about and educate about endometriosis, Marcia Carneiro (Brazil)
  46. The quality of life in patients with superficial and/or deep infiltrative endometriosis who underwent colorectal laparoscopic resection, Francesca Frîncu (Romania)
  47. The recurrence and the pregnancy outcomes of young endometriosis patients based on large-scale clinical data, Jiang Hongyuan (China)
  48. Translocator protein is expressed in human endometrium and endometriosis, Fernando M. Reis (Brazil)
  49. Use of the high-power diode laser in the treatment of peritoneal endometriosis, Priscila Barbosa (Brazil)
FIBROIDS / ADENOMYOSIS
  1. A comparison of outcomes of cesarean myomectomy and cesarean section, Kim Hongbae (Republic of Korea)
  2. A prospective, multi-national, multicentre, non-interventional study to evaluate the long term safety of Ulipristal Acetate 5mg (Esmya®) and the current prescription and management patterns of Esmya® in a long term treatment setting. Results of the second yearly progress report, Pablo Arriagada (Switzerland)
  3. A total of 226 uterine leiomyomas removed by hysteroscopy and laparotomy: a case report, Kihwan Lee (Republic of Korea)
  4. Abdominal desmoid tumor: case report, Giovana Fortunato (Brazil)
  5. Bee propolis a new modality for treatment of uterine myoma, Ali Farid M. Ali (Egypt)
  6. Case series of 30 women with abnormal uterine bleeding and uterine leiomyomas treated with ulipristal acetate continuously for over 6 months, Samantha Benlolo (Canada)
  7. Clinical characteristics of cystic adenomyosis: a report of 13 cases, Erina Satake (Japan)
  8. Clinical follow-up outcomes after laparoscopic myomectomy: 364 patients in a single institute, by a single surgeon, Kwack Jaeyoung (Republic of Korea)
  9. Comparison of reproductive outcomes in patients with symptomatic uterine fibroids after robotic assisted myomectomy versus uterine fibroid embolization (UFE), Maria Anna Kotarska (USA)
  10. Comparison study of single port and multiport laparoscopic myomectomy, Hoe-Saeng Yang (Republic of Korea)
  11. Decreased expression of cannabinoid receptors in the eutopic and ectopic endometrium of patients with adenomyosis, Wang Sha (China)
  12. Development of scoring to accurately predict pelvic adhesions by MRI, Kentaro Ono (Japan)
  13. Development of therapeutic technology through analysis of growth factor of uterine myoma, Mee-Ran Kim (Republic of Korea)
  14. Developmental exposure to endocrine disrupting chemical diethylstilbestrol reprograms the metabolic related genes in myometrial stem cells, Qiwei Yang (USA)
  15. Effect of triptorelin in the treatment of adenomyosis: a multicentre observational study of 465 women in Russia, Tatiana Gorskaya (Russia)
  16. Efficacy and safety of the selective progesterone receptor modulator vilaprisan: a sub-analysis of the ASTEROID 1 trial by ethnicity, Linda Bradley (USA)
  17. Estimation of the quantity and quality of oocytes and embryos in IVF protocols in women with uterine fibroids with and without surgical treatment, Maria Makulova (Russia)
  18. Experience of organ-preserving operations in adenomyosis and reproductive outcomes, Kirill Krylov (Russia)
  19. Factors associated with reinfusion of autologous blood from cell salvage during abdominal myomectomy, Julian Gingold (USA)
  20. Fibroid’s rapid growth after hysteroscopic resection in women treated with preoperative ulipristal acetate, Gracia Meritxell (Spain)
  21. Fibroids and infertility, Roni Arienti (Brazil)
  22. From atypical myoma to uterine sarcoma: about three cases report, Julien Bakenga (France)
  23. Further results on adenomyomectomy with TOUA in a single institute; pregnancy and delivery outcomes, Yong-Soon Kwon (Republic of Korea)
  24. Heat can treat: the treatment of uterine adenomyosis with radiofrequency thermal ablation. Outcome in 120 cases, Marcello Ceccaroni (Italy)
  25. Impact of submucosal fibroid removing on uterine peristaltis and reproduction, Anton Fedorov (Russia)
  26. Impact of the adenomyosis on the quality of life, Gracia Meritxell (Spain)
  27. Impact on quality of life of ulipristal acetate treatment in women with uterine fibromatosis, Stefano Luisi (Italy)
  28. Influence of adenomyosis in work productivity and risk of anxiety and depression: results of a pilot study, Maria-Angeles Martinez-Zamora (Spain)
  29. Influence of hormones disorders on metabolic function of the liver at the hysteromyoma, Umida Sadullayeva (Uzbekistan)
  30. Intravenous leiomyomatosis disguised as a deep vein thrombosis, Suhyun Shim (Republic of Korea)
  31. Laparoscopic versus abdominal myomectomy: comparison of the techniques and selection of patients,Emanuela Spagnolo (Spain)
  32. Liver assessment during ulipristal acetate treatment for uterine fibroids, Blanch Fons Laura (Spain)
  33. Liver safety in women treated with ulipristal acetate: a retrospective record, Alejandro Domenech (Spain)
  34. Localization of angiotensin-(1-7), MAS receptor and type-2 angiotensin converting enzyme in uterine fibroids, Fernando M. Reis (Brazil)
  35. Misclassification pathological report of uterine smooth muscle tumors of uncertain malignant potential (STUMP). A case report, Tongta Nanthakomon (Thailand)
  36. Modalities of ulipristal acetate (UPA) use and impact on the myoma management in France: real life data of SNIIRAM analysis shows a positive impact on surgery decrease, Sylvie Covarrubias (France)
  37. MRI uterine junctional zone thickness and myometrium bright foci predicts IVF failure, Pascal Piver (France)
  38. Myomectomy during cesarian, an ignored opportunity? Patient Wimba Mijiriro (Congo)
  39. Presence of focal adenomyosis based on MRI is associated with presentation for infertility, Mathilde Bourdon (France)
  40. Risk factors for development of venous thromboembolism in patients with large uterine fibroids: a case series and review of the literature, Emmy Cai (Canada)
  41. Robotic Adenomyomectomy combined with TOUA (Transient Occlusion of Uterine Arteries) technique, Kwon Yong-Soon (Republic of Korea)
  42. Role of neurogenic factors in uterine fibroids, Stefano Luisi (Italy)
  43. Simvastatin a new modality for treatment of uterine myoma, Ali Farid M. Ali (Egypt)
  44. Sonographic incidence of adenomyosis in a pelvic pain population, Mohamed Bedaiwy (Canada)
  45. Sphingosine 1-phosphate (S1P) different expression in symptomatic and asymptomatic patients suffering from uterine fibroids: preliminary data, Tommaso Capezzuoli (Italy)
  46. Survey of Portuguese gynaecologists regarding ulipristal acetate safety in the treatment of uterine fibroids, Fernanda Águas (Portugal)
  47. The safety and efficacy of xi single site versus multisite robotic-assisted myomectomy, Aileen Caceres (USA)
  48. Transcutaneous Bee Venom acupoint stimulation a new modality of treatment of uterine myoma, Ali Farid M. Ali (Egypt)
  49. Transcutaneous magnetic acupuncture point stimulation treatment of uterine myoma (modern trend), Ali Farid M. Ali (Egypt)
  50. Ulipristal acetate in treatment of symtomatic fibroids: our experience, Polizzi Serena (Italy)
  51. Uterine artery embolization for symptomatic leiomyoma and follow-up results, Dulat Tazhibaev (Kazakhstan)
  52. Vertical upward migration of dominant fibroids of the uterine isthmus as a result of preoperative use of ulipristal ensures the effectiveness of organ-preserving surgical treatment, Alexander Tikhomirov (Russia)
  53. White spots and contra-version of the pathogenesis and therapy of uterine leiomyoma, Victor Radzinsky (Russia)
INFERTILITY
  1. Art outcomes in endometrioma patients undergoing sclerotherapy versus laparoscopic cystectomy: a clinical trial, Saeed Alborzi (Iran)
  2. Effect of transcutaneous magnetic acupuncture point on multiple icsi failure, Ali Darid M. Ali (Egypt)
  3. Endometriosis related infertility: a retrospective study on reproductive outcome of ART cycles, Tommaso Capezzuoli (Italy)
  4. First live birth after 36 spontaneous early abortion by intra uterine injection of zamzam water, Ali Farid M. Ali (Egypt)
  5. Integrative medicine for infertility management in endometriosis: rural experience, Olarik Musigavong (Thailand)
  6. Letrozole based frozen embryo transfer protocol for patient having adenomyosis, Luan Au (Vietnam)
MINIMALLY INVASIVE SURGERY
  1. An innovative method for immature cervical dilation, Mamia Daoud (France)
  2. Comparison of four different hemostatic devices in laparoscopic myomectomy, Chin-Jung Wang (Province of China Taiwan)
  3. Hysterectomy complication rates by type of menstrual disorder, Yoko Urata (Japan)
  4. Nipple skin sparing Mastectomy by conventional laparoscopic single port: about four cases report, Julien Bakenga (France)
  5. One hundreds single port procedures: tips and tricks, Julien Bakenga (France)
  6. Optimal endometriosis excision to optimize the quality of life and pain control, Pattaya Hengrasmee (Thailand)
  7. Prediction of pouch of Douglas obliteration in women with suspected giant uterine fibroids using a new real-time dynamic transvaginal ultrasound technique: the wave sign, Nishida Hirotaka (Japan)
  8. Robot assisted laparoscopic adenomyomectomy is a feasible option for patients who want to preserve fertility, Youngsin Han (Republic of Korea)
  9. Robotically-assisted laparoscopic ovarian cystectomy using the CO2 laser: a versatile approach to reproductive surgery, Joseph Franzese (USA)
  10. Successful laparoscopic surgery of accessory cavitated uterine mass in young women with severe dysmenorrhea, Joon Cheol Park (Republic of Korea)
  11. The results of McIndoe vaginoplasty in patients with vaginal aplasia; long term follow up, Tahereh Poordast (Iran)
  12. Transumbilical cord access (TUCA) for laparoscopy, Mamia Daoud (France)
  13. True transvaginal (N.O.S.) myomectomy, Vladimir Durasov (Russia)
  14. Uterine artery ligation at its origin following retroperitoneal space development decreases blood loss during single-port total laparoscopic hysterectomy, Kim Tae-Joong (Republic of Korea)
PAIN
OTHER
  1. Analysis of factors affecting the recurrence cervical cancer, Nargiza Karimova (Uzbekistan)
  2. Disturbed sleep in endometriosis: pilot observations, Irina Kuznetsova (Russia)
  3. Endometriosis and adverse pregnancy outcomes: the role of impaired decidualization, Louis Marcellin (France)
  4. Evaluation of hematologic parameters in adnexal torsion, Jisun Lee (Republic of Korea)
  5. Evaluation of safety and satisfaction after CO2 laser treatment in post-menopausal women affected by vaginal atrophy: a prospective observational study, Violante Di (Italy)
  6. Multislice tomography in the comparative assessment of the rate of primary tumor regression against the background of chemoradiation therapy for locally advanced cervical cancer, Nargiza Karimova (Uzbekistan)
  7. Multislice tomography in the comparative assessment of the rate of primary tumor regression against the background of chemoradiation therapy for locally advanced cervical cancer, Nargiza Karimova (Uzbekistan)
  8. Place of surgery in the management of gestational trophoblastic tumors, Lyes Meguenni (Algeria)
  9. Preliminary evaluation of CO2 fractional laser treatment impact on female sexual function and distress in women with vulvovaginal atrophy: a prospective observational study, Violante Di Donato (Italy)
  10. Preliminary evaluation of the efficacy of fractional CO2 laser on symptoms associated with vulvovaginal atrophy (VVA): a prospective observational study, Violante Di Donato (Italy)
  11. Primary amenorrhea: case report, Michelle Martins (Brazil)
  12. The diagnostic value of multispiral tomography in assessing the effectiveness of treatment in the lymph nodes of locally advanced forms of cervical cancer, Nargiza Karimova (Uzbekistan)